All Articles by Louis Basenese

  • Raise Your Sell Stop

    January 25, 2012

    In less than two weeks, we’re up 14% in what was supposed to be a more conservative, income-producing recommendation for us. But let’s not argue with the strength.

  • Change is Coming!

    January 23, 2012

    If you’ve been paying careful attention to our weekly broadcasts, no doubt you’ve noticed our new look. For the less observant, let this be your official notice that we’re updating our design to match that of our free site, Wall Street Daily.

  • New Profits in 8×8

    January 20, 2012

    Yesterday shares of the VoIP and cloud computing services provider surged 25% on almost ten times average volume. So what happened?

  • It’s Time to Buy This Natural Gas Play

    January 13, 2012

    Albert Einstein famously said, “Necessity is the mother of all invention.” And that’s certainly true when it comes to the next company we’re adding to our portfolio.

  • MAKO Surges and Earnings Season Officially Gets Underway

    January 11, 2012

    Outside an unsolicited takeover offer, there’s not much that consistently sparks a sudden jump in share prices more than a strong earnings report. And we fully expect our recommended companies to deliver one strong report after another.

  • The Myth About Stock Splits

    January 9, 2012

    As you know, one of the mandates for our free investment e-letter, Wall Street Daily, is to debunk Wall Street myths. And in our Mailbag today, we’re doing just that. Debunking the myth about stock splits. In this case, reverse stock splits.

  • Letting it Ride in 2012!

    January 6, 2012

    When we first married your love for risky investments with our obsession for
    good old-fashioned risk-reduction strategies to create the $1,000 “Let it Ride”
    Portfolio, we embraced a single philosophy…

  • ** Portfolio Update

    January 6, 2012

    Please Log In Type your username and password into the form below. Username Password Log InLost Your Password?

  • The White Cap Research Group: Urgent Sell Notice – January 5, 2012

    January 5, 2012

    The company was sitting on a goldmine of intellectual property – worth more than $3 billion – just waiting to be unearthed. And that still holds true. But it appears increasingly likely that the company is going to file for bankruptcy protection before it monetizes those assets.

  • A Final Note and Investment Opportunity for 2011

    December 28, 2011

    So is Gigoptix really a takeover target? Management obviously thinks so. And so do I. Especially since the company holds 108 patents and 40 patent applications, including ones related to high-speed information streaming, which are increasingly valuable in our mobile world.

  • Even More Reasons to Buy AVAV and Japan

    December 21, 2011

    Despite a tough year for Japan and its stock market, I’m convinced that 2012 could be an entirely different story. And that’s not just because Japanese stocks are historically cheap in comparison to U.S. stocks. It’s also because the Japanese economy is on the mend.

  • A Challenge for You As We Head into 2012

    December 19, 2011

    Our offices are closed next Monday, so this is our last Mailbag and Smash Hit or Trash It! column of 2011. Do we have anything special lined up to commemorate the occasion? Nope.

  • We’ve Hit Our Stop on Fusion-io

    December 12, 2011

    So be disciplined and close out your position if you haven’t done so already. And I’ll continue to monitor the price action to determine whether a re-entry makes sense.

  • An Important Reminder About “Chasing Yield”

    December 5, 2011

    We’re putting the finishing touches on the next issue of The White Cap Report – scheduled for release on Wednesday – so I’m going to cut right to the chase today.

  • We’re Jumping Back into MAKO

    November 30, 2011

    You’ll recall that MAKO is the maker of the Robotic Arm Interactive Orthopedic (RIO) System. It’s used in conjunction with the company’s implants to perform MAKOplasty – a minimally invasive surgery that treats early to mid-stage osteoarthritic knee disease.

  • A Note of Thanks…

    November 28, 2011

    Moving onto less significant matters, our inbox is looking a bit empty. So now that we’re back to business after Thanksgiving, make sure you fire a fresh batch of questions for us to answer in our Mailbag each Monday.